Close
Back to PAND Stock Lookup

(PAND) –

Apr 12, 2021 06:55 AM Form 15-12B Pandion Therapeutics,
Apr 8, 2021 05:25 PM Form SC 13D/A Pandion Therapeutics, Filed by: GLAXOSMITHKLINE PLC
Apr 6, 2021 06:05 AM Form EFFECT Pandion Therapeutics,
Apr 6, 2021 06:04 AM Form EFFECT Pandion Therapeutics,
Apr 2, 2021 09:54 AM Form SC 13D/A Pandion Therapeutics, Filed by: AI Pan LLC
Apr 1, 2021 07:59 PM Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Viney Joanne L.
Apr 1, 2021 07:59 PM Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Goyal Vikas
Apr 1, 2021 07:57 PM Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Crane Alan L
Apr 1, 2021 07:56 PM Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Freedman Edward D.
Apr 1, 2021 07:54 PM Form 4 Pandion Therapeutics, For: Apr 01 Filed by: BELOFF GREGG
Apr 1, 2021 07:50 PM Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Kakkar Rahul
Apr 1, 2021 07:50 PM Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Becker Daniel J.
Apr 1, 2021 07:50 PM Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Fuglesang Christopher
Apr 1, 2021 07:47 PM Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Sundy John
Apr 1, 2021 07:46 PM Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Stagliano Nancy
Apr 1, 2021 07:46 PM Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Dorton Katina
Apr 1, 2021 07:45 PM Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Frail Donald
Apr 1, 2021 07:43 PM Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Carroll Jill
Apr 1, 2021 07:39 PM Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Carlo Rizzuto
Apr 1, 2021 07:38 PM Form 4 Pandion Therapeutics, For: Apr 01 Filed by: Larson Eric D
Apr 1, 2021 08:50 AM Form S-8 POS Pandion Therapeutics,
Apr 1, 2021 08:49 AM Form S-8 POS Pandion Therapeutics,
Apr 1, 2021 08:48 AM Form POS AM Pandion Therapeutics,
Apr 1, 2021 08:47 AM Form POS AM Pandion Therapeutics,
Apr 1, 2021 08:45 AM Form 8-K Pandion Therapeutics, For: Apr 01
Apr 1, 2021 08:44 AM Form SC 14D9/A Pandion Therapeutics, Filed by: Pandion Therapeutics, Inc.
Apr 1, 2021 08:38 AM Form SC TO-T/A Pandion Therapeutics, Filed by: MERCK SHARP & DOHME CORP.
Apr 1, 2021 08:35 AM Merck (MRK) Completes Acquisition of Pandion Therapeutics (PAND)
Apr 1, 2021 08:30 AM Merck Completes Acquisition of Pandion Therapeutics
Apr 1, 2021 08:26 AM Form 25-NSE Pandion Therapeutics, Filed by: Nasdaq Stock Market LLC
Mar 31, 2021 04:03 PM Form 10-K/A Pandion Therapeutics, For: Dec 31
Mar 22, 2021 04:32 PM Form SC TO-T/A Pandion Therapeutics, Filed by: MERCK SHARP & DOHME CORP.
Mar 22, 2021 04:22 PM Form SC 14D9/A Pandion Therapeutics, Filed by: Pandion Therapeutics, Inc.
Mar 12, 2021 05:05 PM Form S-8 Pandion Therapeutics,
Mar 12, 2021 04:41 PM Form 10-K Pandion Therapeutics, For: Dec 31
Mar 4, 2021 05:16 PM Form SC 14D9 Pandion Therapeutics, Filed by: Pandion Therapeutics, Inc.
Mar 4, 2021 04:49 PM Form SC 13D Pandion Therapeutics, Filed by: AI Pan LLC
Mar 4, 2021 04:35 PM Form SC TO-T Pandion Therapeutics, Filed by: MERCK SHARP & DOHME CORP.
Mar 4, 2021 06:48 AM Merck (MRK) Begins Tender Offer to Acquire Pandion Therapeutics (PAND)
Mar 4, 2021 06:45 AM Merck Begins Tender Offer to Acquire Pandion Therapeutics
Mar 4, 2021 06:08 AM Form 3 Pandion Therapeutics, For: Feb 24 Filed by: MERCK SHARP & DOHME CORP.
Mar 4, 2021 06:08 AM Form SC 13D Pandion Therapeutics, Filed by: Merck & Co., Inc.
Feb 26, 2021 04:59 PM Form SC14D9C Pandion Therapeutics, Filed by: Pandion Therapeutics, Inc.
Feb 26, 2021 04:43 AM SVB Leerink Downgrades Pandion Therapeutics (PAND) to Market Perform
Feb 25, 2021 04:02 PM Form SC TO-C Pandion Therapeutics, Filed by: MERCK SHARP & DOHME CORP.
Feb 25, 2021 01:43 PM Morgan Stanley Downgrades Pandion Therapeutics (PAND) to Equalweight, Following Acquisition
Feb 25, 2021 11:49 AM PANDION ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of PAND and Encourages Investors to Contact the Firm
Feb 25, 2021 09:28 AM Pre-Open Stock Movers 02/25: (PAND) (GME) (KOSS) Higher; (PING) (GPRE) (PZZA) Lower (more...)
Feb 25, 2021 08:20 AM Form 8-K Pandion Therapeutics, For: Feb 24
Feb 25, 2021 06:46 AM Merck (MRK) to Acquire Pandion Therapeutics (PAND) for $60/Share in $1.85 Billion Deal

Back to PAND Stock Lookup